نتایج جستجو برای: myelodysplastic syndrome

تعداد نتایج: 625034  

Journal: :Haematologica 2012
Carlos Santamaría Sandra Muntión Beatriz Rosón Belén Blanco Olga López-Villar Soraya Carrancio Fermín M Sánchez-Guijo María Díez-Campelo Stela Alvarez-Fernández María E Sarasquete Javier de las Rivas Marcos González Jesús F San Miguel María Consuelo Del Cañizo

UNLABELLED Background Recent findings suggest that a specific deletion of Dicer1 in mesenchymal stromal cell-derived osteoprogenitors triggers several features of myelodysplastic syndrome in a murine model. Our aim was to analyze DICER1 and DROSHA gene and protein expression in mesenchymal stromal cells (the osteoblastic progenitors) obtained from bone marrow of myelodysplastic syndrome patient...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Lilia Suárez María-Belén Vidriales José García-Laraña Guillermo Sanz María-José Moreno Antonio López Susana Barrena Rafael Martínez Mar Tormo Luis Palomera Esperanza Lavilla Ma Consuelo López-Berges María de Santiago M Encarnación Pérez de Equiza Jesús F San Miguel Alberto Orfao

Myelodysplastic syndromes and acute myeloid leukemia (AML) are heterogeneous disorders in which conflicting results in apoptosis and multidrug resistance (MDR) have been reported. We have evaluated by multiparameter flow cytometry the expression of apoptosis- (APO2.7, bcl-2, and bax) and MDR-related proteins [P-glycoprotein (P-gp), multidrug resistance protein (MRP), and lung resistance protein...

Journal: :Haematologica 2015
Michael Y Zhang Siobán B Keel Tom Walsh Ming K Lee Suleyman Gulsuner Amanda C Watts Colin C Pritchard Stephen J Salipante Michael R Jeng Inga Hofmann David A Williams Mark D Fleming Janis L Abkowitz Mary-Claire King Akiko Shimamura

Accurate and timely diagnosis of inherited bone marrow failure and inherited myelodysplastic syndromes is essential to guide clinical management. Distinguishing inherited from acquired bone marrow failure/myelodysplastic syndrome poses a significant clinical challenge. At present, diagnostic genetic testing for inherited bone marrow failure/myelodysplastic syndrome is performed gene-by-gene, gu...

2017
Manja Meggendorfer Claudia Haferlach Wolfgang Kern Torsten Haferlach

The only cytogenetic aberration defining a myelodysplastic syndrome subtype is the deletion of the long arm of chromosome 5, which, along with morphological features, leads to the diagnosis of myelodysplastic syndrome with isolated deletion of the long arm of chromosome 5. These patients show a good prognosis and respond to treatment such as lenalidomide, but some cases progress to acute myeloi...

Journal: :Haematologica 2014
Tung-Liang Lin Yasunobu Nagata Hsiao-Wen Kao Masashi Sanada Yusuke Okuno Chein-Fuang Huang Der-Cherng Liang Ming-Chung Kuo Chang-Liang Lai En-Hui Lee Yu-Shu Shih Hiroko Tanaka Yuichi Shiraishi Kenichi Chiba Tung-Huei Lin Jin-Hou Wu Satoru Miyano Seishi Ogawa Lee-Yung Shih

Somatic mutations of TET2, IDH1, and IDH2 have been described in myelodysplastic syndrome. The impact of these mutations on outcome of myelodysplastic syndrome and their progression to secondary acute myeloid leukemia remains unclear. Mutation status of TET2, IDH1 and IDH2 was investigated in a cohort of 46 paired myelodysplastic syndrome/acute myeloid leukemia samples and 122 non-paired cases ...

2016
Michael M. Shalaby Ryan R. Riahi Les B. Rosen Erik J. Soine

The neutrophilic dermatoses are a group of disorders characterized by skin lesions for which histological examination reveals intense epidermal and/or dermal inflammatory infiltrates composed primarily of neutrophils without evidence of infection. The myelodysplastic syndromes consist of a heterogeneous group of malignant hematopoietic stem cell disorders characterized by dysplastic and inadequ...

Journal: :Haematologica 2009
Martine E D Chamuleau Theresia M Westers Linda van Dreunen Judith Groenland Adri Zevenbergen Corien M Eeltink Gert J Ossenkoppele Arjan A van de Loosdrecht

BACKGROUND An activated immune system has been observed in patients with myelodysplastic syndrome but its exact contribution to disease development and control is not fully clarified. On the one hand an activated and skewed T-cell repertoire has been reported, but on the other hand, decreased natural killer cell function has been found. Immune activation could reflect undesired autoimmune react...

Journal: :international journal of molecular and cellular medicine 0
farhad zaker cellular and molecular research center, iran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences) naser amirizadeh blood transfusion research center, high institute for education and research in transfusion medicine, tehran, iran.سازمان اصلی تایید شده: سازمان انتقال خون ایران (blood transfusion research center) nahid nasiri department of hematology, school of allied medicine, iran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences) seyed mohsen razavi hematology and oncology department, firoozgar hospital, iran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences) ladan teimoori-toolabi molecular medicine department, biotechnology research center, pasteur institute of iran, tehran, iran.سازمان اصلی تایید شده: انستیتو پاستور ایران (pasteur institute of iran) marjan yaghmaie hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

myelodysplastic syndromes (mdss) are a clonal bone marrow (bm) disease characterized by ineffective hematopoiesis, dysplastic maturation and progression to acute myeloid leukemia (aml). methylation silencing of hrk has been found in several human malignancies. in this study, we explored the association of hrk methylation status with its expression, clinical parameters and mds subtypes in mds pa...

Journal: :Haematologica 2008
Ghulam J Mufti John M Bennett Jean Goasguen Barbara J Bain Irith Baumann Richard Brunning Mario Cazzola Pierre Fenaux Ulrich Germing Eva Hellström-Lindberg Itsuro Jinnai Atsushi Manabe Akira Matsuda Charlotte M Niemeyer Guillermo Sanz Masao Tomonaga Teresa Vallespi Ayami Yoshimi

The classification of myelodysplastic syndromes is based on the morphological criteria proposed by the French-American-British (FAB) and World Health Organization (WHO) groups. Accurate enumeration of blast cells, although essential for diagnosis of myelodysplastic syndrome and for assignment to prognostic groups, is often difficult, due to imprecise criteria for the morphological definition of...

2010
Geetanjali Gupta Reecha Singh Dhananjay S Kotasthane Vaishali D Kotasthane

The myelodysplastic Syndromes (MDS) are a group of clonal hematopoietic stem cell diseases characterized by cytopenia(s), dysplasia in one or more of the major myeloid cell lines, ineffective hematopoiesis, and increased risk of development of acute myeloid leukemia. The classification and the diagnostic criteria have been redefined by the recent World Health Organization Classification of Tumo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید